Navigation Links
Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Date:11/13/2008

CORONA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for a 6-month formulation of TRELSTAR(R) (triptorelin pamoate), a luteinizing hormone releasing hormone (LHRH) agonist, has been accepted for filing by the U.S. Food and Drug Administration (FDA). Watson is seeking marketing approval of this TRELSTAR(R) formulation for the palliative treatment of advanced prostate cancer. Watson anticipates that FDA will take action on its application in the third quarter 2009.

The sustained-release formulation of TRELSTAR(R) is designed to suppress the production of testosterone in men with advanced prostate cancer over 6 months. Prostate cancer growth is regulated in part by the level and activity of testosterone.

"This filing reflects Watson's commitment to urology and to making a difference in the lives of men living with prostate cancer," said Paul Bisaro, Watson's President and Chief Executive Officer. "This new longer duration TRELSTAR(R) formulation requires only one injection every 24 weeks, and showed comparable efficacy and safety with our marketed TRELSTAR(R) 1 and 3-month formulations. The TRELSTAR(R) 6-month formulation should be a welcome alternative for men and their physicians and will be a significant addition to our expanding urology portfolio."

About TRELSTAR(R)

TRELSTAR(R), developed by Debiopharm Group, a Swiss biopharmaceutical development specialist, and marketed by Watson Pharma, Inc., is a synthetic hormone known as a luteinizing hormone releasing hormone (LHRH) agonist, which suppresses the production of testosterone in the testicles. The growth of the prostate is reg
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine news :

1. Watson Pharmaceuticals Reports Third Quarter 2008 Results
2. Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
3. Older Workers Worried About Promised Medicare and Social Security Benefits, Watson Wyatt Survey Finds
4. Watson Wyatt Identifies Trends for Benefits Open Enrollment Season
5. Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
6. Watson Announces Limited Recall of Fentanyl Transdermal System
7. Watson Launches Omeprazole Delayed-Release Capsules, 40MG
8. Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris
9. Watson Launches Generic MARINOL(R) Capsules
10. Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
11. Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... 3D Global Solutions is pleased to a...aging the proposal effort for ReSound who recently...Hearing Aid contract. The award includes not only ...nt of Defense and other federal agencies. , ..., 2009 -- 3D Global Solutions is pleased to announ...
(Date:11/8/2009)... Men’s Health Network (MHN) ur...risks, especially those linked to exposure to chem...ry service. Bladder cancer is one of those cancers...ecially those who once smoked or currently smoke c...C (PRWEB) November 8, 2009 -- Men’s Health N...
(Date:11/8/2009)...NGTON, Nov. 7 Today, th...s, Kaptur, Dahlkemper, Smith, Ellsworth and Lipins...erica Act" (H.R. 3962). The amendment maintains th... abortion and for benefits packages that include a... who receive affordability credits and those who d...
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
(Date:11/8/2009)...NGTON, Nov. 8 Pharmaceu...) Senior Vice President Ken Johnson released the f... reform bill: ,, "We are disappointed, but not ...by millions of hardworking Americans as well as ne...esentatives who voted against the bill. ,, "Whi...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
..., symptoms of schizophrenia can be relieved by mus...llege London conducted a study in 4 hospitals and ... patients when they were encouraged to express the...d when people are fairly stable," said Dr Mike Cra...
...nly prescribed invasive test performed during preg... while doctors// recommend them based on guideline...ynecologists. These guidelines stem from past rese...ases the rate of miscarriage by 0.5% or 1 in 200 p...
...t to seek medical treatment to correct the malady,...y of 10,900 men found erectile problems affected 5...laysia and Japan, the South China Morning Post sai...id just 36 percent of them seek medical help. ...
... Alois Alzheimer presented a paper entitled "Regar...heimer's colleagues did not immediately recognise ..., the name of Alois Alzheimer (1864-1915) is known...after the scientist. Worldwide over 20 million are...
...f company and sad and lonely at the end of a day g...e cortisol in their blood the next morning,// rese... National Academy of Sciences USA. Hormone co...n a radical study the first of its kind, daily exp...
... breasts pierced for her 18th birthday suffered ne... doctors to surgically remove her left// breast. S...n right up to Stephanie Edington’s collar bone las...with gas gangrene or necrotizing fasciitis a very ...
Other Medicine News:Health News:Amniocentesis Safer for Pregnant Women 2Health News:Alzheimer's - From Curiosity To Worldwide Disease 2
(Date:11/6/2009)...re/ -- Trius Therapeutics, Inc. announced today th...-1 with the U.S. Securities and Exchange Commissio...ring of shares of its common stock. All shares of ...e offered by the Company. ,, Credit Suisse Secu...nager, Piper Jaffray & Co. is acting as co-lea...
(Date:11/6/2009)...ewswire-FirstCall/ -- Roper Industries, Inc. (NY...finitive agreement to acquire Verathon, Inc., a le...e Verathon Board of Directors has approved the tra...egulatory approvals and closing conditions, includ...closing to be completed in early December. ,, ...
(Date:11/6/2009)...Newswire-FirstCall/ -- Derma Sciences, Inc. (O...ound care products, announced plans to release its...y, November 16, 2009. The Company will hold a conf...t 11:00 am EST. Interested parties should call (86...ional), with passcode 81416481 to access the call....
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2GlaxoSmithKline Opens 24600million Vaccine Plant In Singapore 48992 1GlaxoSmithKline Opens 24600million Vaccine Plant In Singapore 48992 2GlaxoSmithKline Opens 24600million Vaccine Plant In Singapore 48992 3Man Discovers Cure for Excessive Sweating 48990 1Man Discovers Cure for Excessive Sweating 48990 2New Source of Information on Pulmonary Hypertension Medications 48988 1New Source of Information on Pulmonary Hypertension Medications 48988 2
...entific,data submitted in recent months to the U.S...n for the March 13th Oncologic Drugs Advisory Comm...-stimulating agents (ESAs) are,safe and effective ...chemotherapy- induced anemia (CIA). ESAs are an im...nly proven therapeutic alternative to blood,transf...
...gnificantly Improves Effectiveness of RNAi ..., March 10 Thermo Fisher,Scientific Inc. (NYSE: ...veloped a breakthrough gene-silencing tool that gr...gy and eliminates barriers associated with,previou...ed to accelerate,research and drug discovery in ma...
Other Medicine Technology:Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 2Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 3Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 4Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 5Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia 6Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 2Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 3
Soflens66 Toric
Acuvue Toric
Binocular Loupe C 2.3 x 340mm (13in) with Case
Binocular Loupe C 2.3 x 340 K with Case
Medicine Products: